中国医药
中國醫藥
중국의약
China Medicine
2015年
12期
1841-1845
,共5页
药剂科%中西药物合用%消化性疾病%合理用药
藥劑科%中西藥物閤用%消化性疾病%閤理用藥
약제과%중서약물합용%소화성질병%합리용약
Pharmacy%Chinese and western medicine combination%Digestive disorders%Rational drug use
目的 分析药剂科在医院合理使用中西药物联合治疗消化性疾病中的作用.方法 选择2011年1月至2013年1月在新疆维吾尔自治区人民医院接受治疗的、符合纳入标准的消化性疾病患者300例,按照随机数字表法将患者分为对照组(149例)与观察组(151例).对照组患者采用常规中西药联合治疗,本院药剂科工作人员不给予干预,观察组患者在进行中西药物联合治疗的同时,药剂科相关工作人员积极地参与其中,协助临床医师进行临床用药.治疗3个月后,对2组患者进行疗效评价.结果 观察组中西药物联合治疗的总有效率,适应性、药物剂量和给药方式合理性、不良反应、联合用药的合理性、用药期间的治疗费用及显效时间均明显优于对照组[总有效率:94.0％(142/151)比77.9％(116/149),适应性:合理80.8％(122/151)比65.1％(97/149)、基本合理19.2％ (29/151)比26.2％(39/149)、不合理0.0％(0/151)比8.7％(13/149),药物剂量和给药方式合理性:合理65.6％ (99/151)比59.7％(89/149),不良反应:合理74.8％(113/151)比51.0％(76/149)、基本合理25.2％ (38/151)比14.8％(22/149)、不合理0.0％ (0/151)比34.2％(51/149);联合用药合理性:72.2％(109/151)比61.9％ (92/149);用药期间的治疗费用:(1 252±414)元比(2 070 ±339)元;显效时间:(48±8)d比(58±10)d],差异均有统计学意义(均P＜0.05).结论 药剂科积极参与中西药物联合应用的用药管理,可以更好地促进临床用药的合理性.
目的 分析藥劑科在醫院閤理使用中西藥物聯閤治療消化性疾病中的作用.方法 選擇2011年1月至2013年1月在新疆維吾爾自治區人民醫院接受治療的、符閤納入標準的消化性疾病患者300例,按照隨機數字錶法將患者分為對照組(149例)與觀察組(151例).對照組患者採用常規中西藥聯閤治療,本院藥劑科工作人員不給予榦預,觀察組患者在進行中西藥物聯閤治療的同時,藥劑科相關工作人員積極地參與其中,協助臨床醫師進行臨床用藥.治療3箇月後,對2組患者進行療效評價.結果 觀察組中西藥物聯閤治療的總有效率,適應性、藥物劑量和給藥方式閤理性、不良反應、聯閤用藥的閤理性、用藥期間的治療費用及顯效時間均明顯優于對照組[總有效率:94.0％(142/151)比77.9％(116/149),適應性:閤理80.8％(122/151)比65.1％(97/149)、基本閤理19.2％ (29/151)比26.2％(39/149)、不閤理0.0％(0/151)比8.7％(13/149),藥物劑量和給藥方式閤理性:閤理65.6％ (99/151)比59.7％(89/149),不良反應:閤理74.8％(113/151)比51.0％(76/149)、基本閤理25.2％ (38/151)比14.8％(22/149)、不閤理0.0％ (0/151)比34.2％(51/149);聯閤用藥閤理性:72.2％(109/151)比61.9％ (92/149);用藥期間的治療費用:(1 252±414)元比(2 070 ±339)元;顯效時間:(48±8)d比(58±10)d],差異均有統計學意義(均P＜0.05).結論 藥劑科積極參與中西藥物聯閤應用的用藥管理,可以更好地促進臨床用藥的閤理性.
목적 분석약제과재의원합리사용중서약물연합치료소화성질병중적작용.방법 선택2011년1월지2013년1월재신강유오이자치구인민의원접수치료적、부합납입표준적소화성질병환자300례,안조수궤수자표법장환자분위대조조(149례)여관찰조(151례).대조조환자채용상규중서약연합치료,본원약제과공작인원불급여간예,관찰조환자재진행중서약물연합치료적동시,약제과상관공작인원적겁지삼여기중,협조림상의사진행림상용약.치료3개월후,대2조환자진행료효평개.결과 관찰조중서약물연합치료적총유효솔,괄응성、약물제량화급약방식합이성、불량반응、연합용약적합이성、용약기간적치료비용급현효시간균명현우우대조조[총유효솔:94.0％(142/151)비77.9％(116/149),괄응성:합리80.8％(122/151)비65.1％(97/149)、기본합리19.2％ (29/151)비26.2％(39/149)、불합리0.0％(0/151)비8.7％(13/149),약물제량화급약방식합이성:합리65.6％ (99/151)비59.7％(89/149),불량반응:합리74.8％(113/151)비51.0％(76/149)、기본합리25.2％ (38/151)비14.8％(22/149)、불합리0.0％ (0/151)비34.2％(51/149);연합용약합이성:72.2％(109/151)비61.9％ (92/149);용약기간적치료비용:(1 252±414)원비(2 070 ±339)원;현효시간:(48±8)d비(58±10)d],차이균유통계학의의(균P＜0.05).결론 약제과적겁삼여중서약물연합응용적용약관리,가이경호지촉진림상용약적합이성.
Objective To analyze the value of pharmacy for rational use of Chinese and western medicine combination therapy treating digestive diseases.Methods Totally 300 patients with digestive diseases from January 2011 to January 2013 were randomly divided into control group (149 cases) and observation group (151 cases).Control group was given conventional combination therapy of Chinese and western medicine without intervene from pharmacy;observation group was given additional intervene from pharmacy to assist the medication.After 3 months of treatment, the curative effect was evaluated between the two groups.Results The total efficiency, adaptability, reasonability of dosage and administration mode, adverse reactions, reasonability of drug combination, treatment cost and effective time in observation group were better than those in control group [total efficiency: 94.0％ (142/151) vs 76.8％ (116/149);adaptability: reasonable 80.8％ (122/151) vs 65.1％ (97/149), basically reasonable 19.2％ (29/151) vs 26.2％ (39/149) , unreasonable 0.0％ (0/151)vs 8.7％ (13/149);reasonability of drug dosage and administration mode: 65.6％ (99/151) vs 59.7％(89/149);adverse reactions : reasonable 74.8％ (113/151) vs 51.0％ (76/149), basically reasonable 25.2％(38/151) vs 14.8％ (22/149), unreasonable 0.0％ (0/151) vs 34.2％ (51/149);reasonability of drug combination: 72.2％ (109/151) vs 60.9％ (92/149);treatment cost: (1 252 ± 414) yuan vs (2 070 ±339) yuan;effectivetime: (48 ± 8) d vs (58 ± 10) d] (P ＜ 0.05).Conclusion Active involvement of pharmacy in medication management of Chinese and western medicine combination can promote rational clinical use of drugs.
